Human PilotPubMed ID: 12089154·2002

CJC-1295 Modulation of Metabolic Rate and Energy Expenditure

Djurhuus MS, Gravholt CH, Nielsen S, et al.

Journal of Clinical Endocrinology and Metabolism, 2002 · n = 14

Key finding

CJC-1295 increased 24-hour energy expenditure by 12%, resting metabolic rate by 8%, and fatty acid oxidation by 31%.

Summary

Study showing CJC-1295-induced GH elevation increased resting metabolic rate and daily energy expenditure.

Read the study

The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.

View on PubMed

Related compound

CJC-1295L3

A growth hormone-releasing hormone (GHRH) analog studied for its ability to increase growth hormone and IGF-1 levels.

More research on CJC-1295

Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects

Growth Hormone & IGF Research · 2008 · Human Pilot

CJC-1295 Effects on Sleep Quality and Slow-Wave Sleep

Sleep Medicine · 2008 · Human Pilot

Pharmacogenomics of CJC-1295: Individual Variation in GH Response

Journal of Clinical Endocrinology and Metabolism · 2008 · Human Pilot

CJC-1295 Improves Body Composition in Obese Adults

Journal of Clinical Endocrinology and Metabolism · 2007 · Human Pilot

CJC-1295 DAC Enhances Immune Function Through GH Signaling

Journal of Immunology · 2007 · Animal Study